ACT-1016-0707 - CAS 2569467-78-1

ACT-1016-0707 is a potent, selective, and insurmountable lysophosphatidic acid receptor 1 (LPA1) antagonist, ACT-1016-0707 demonstrates pronounced antifibrotic and anti-inflammatory activities in experimental models. ACT-1016-0707 has been studied extensively in vitro and in vivo lung fibrosis models, where it reduces pathological fibrotic progression, thereby representing a candidate compound for research into fibrotic lung diseases.

LPA Receptor, LPL Receptor

GPCR/G Protein

2569467-78-1

0.99905

C19H23ClN4O4S

438.93

C(NC=1C(OC)=CC(Cl)=NC1)(=O)C2(CN(S(N)(=O)=O)C2)C3=C(C(C)C)C=CC=C3

-20°C

Ice Packs

Small Compound